BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 33346460)

  • 1. The role of contraindications in prescribing anticoagulants to patients with atrial fibrillation: a cross-sectional analysis of primary care data in the UK.
    Adderley N; Ryan R; Marshall T
    Br J Gen Pract; 2017 Sep; 67(662):e588-e597. PubMed ID: 28630059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower Oral Anticoagulant Prescribing for Atrial Fibrillation in Women Compared With Men.
    Manja V; Phibbs CS; Ananth L; Saechao F; Frayne SM
    Am J Cardiol; 2024 May; 219():44-46. PubMed ID: 38548010
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of a National Health Service Electronic Prescriptions Database in the Detection of Prescribing and Dispensing Issues and Adherence Evaluation of Direct Oral Anticoagulants.
    Gavrilova A; Zolovs M; Šmits D; Ņikitina A; Latkovskis G; Urtāne I
    Healthcare (Basel); 2024 May; 12(10):. PubMed ID: 38786385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of risk factors and drug adherence in the occurrence of stroke in patients with atrial fibrillation.
    El-Hajj M; Ajrouche R; Zein S; Rachidi S; Awada S; Al-Hajje A
    Pharm Pract (Granada); 2020; 18(2):1860. PubMed ID: 32566048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary outcomes of acute ischemic stroke in atrial fibrillation patients on anticoagulation.
    Vasquez MA; Lambrakos LK; Velasquez A; Goldberger JJ; Mitrani RD
    J Stroke Cerebrovasc Dis; 2024 May; 33(8):107790. PubMed ID: 38788986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical decisions for appropriate management of patients with atrial fibrillation.
    Boriani G; Bonini N; Imberti JF; Vitolo M; Gerra L; Mantovani M; Serafini K; Birtolo C; Tartaglia E; Mei DA
    Panminerva Med; 2024 Apr; ():. PubMed ID: 38656767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of adherence to antithrombotic therapy in patients with atrial fibrillation during the COVID-19 pandemic.
    Tulepbergenov G; Almukhanova A; Ospanova D; Zhangelova S; Musayev A; Akhmetova G; Mambetova I; Кapsultanova D
    Med J Malaysia; 2023 Jul; 78(4):445-448. PubMed ID: 37518910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [EndoFrance: support, inform, act].
    Candau Y
    Rev Infirm; 2024 Mar; 73(299):36. PubMed ID: 38485401
    [No Abstract]   [Full Text] [Related]  

  • 9. Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?
    Alamneh EA; Chalmers L; Bereznicki LR
    Am J Cardiovasc Drugs; 2016 Jun; 16(3):183-200. PubMed ID: 26862063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to oral anticoagulant therapy in patients with atrial fibrillation. Focus on non-vitamin K antagonist oral anticoagulants.
    Raparelli V; Proietti M; Cangemi R; Lip GY; Lane DA; Basili S
    Thromb Haemost; 2017 Jan; 117(2):209-218. PubMed ID: 27831592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of decision support system implementation for prescribing anticoagulants to patients with atrial fibrillation in hospital].
    Chernov AA; Kleymenova EB; Sychev DA; Yashina LP; Nigmatkulova MD; Otdelenov VA; Payushchik SA
    Ter Arkh; 2020 Sep; 92(8):37-42. PubMed ID: 33346460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of anticoagulants in the management of atrial fibrillation among general practices in England.
    Cowan C; Healicon R; Robson I; Long WR; Barrett J; Fay M; Tyndall K; Gale CP
    Heart; 2013 Aug; 99(16):1166-72. PubMed ID: 23393083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appropriateness of prescription of oral anticoagulant therapy in acutely hospitalized older people with atrial fibrillation. Secondary analysis of the SIM-AF cluster randomized clinical trial.
    Antoniazzi S; Ardoino I; Proietti M; Monzani V; Mannucci PM; Nobili A; Franchi C;
    Br J Clin Pharmacol; 2019 Sep; 85(9):2134-2142. PubMed ID: 31218738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II).
    Steinberg BA; Shrader P; Pieper K; Thomas L; Allen LA; Ansell J; Chan PS; Ezekowitz MD; Fonarow GC; Freeman JV; Gersh BJ; Kowey PR; Mahaffey KW; Naccarelli GV; Reiffel JA; Singer DE; Peterson ED; Piccini JP;
    J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29453305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flaws in Anticoagulation Strategies in Patients With Atrial Fibrillation at Hospital Discharge.
    Kartas A; Samaras A; Vasdeki D; Dividis G; Fotos G; Paschou E; Forozidou E; Tsoukra P; Kotsi E; Goulas I; Efthimiadis G; Karvounis H; Tzikas A; Giannakoulas G
    J Cardiovasc Pharmacol Ther; 2019 May; 24(3):225-232. PubMed ID: 30599759
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.